Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03994627
Title Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

sarcoma

Therapies

Olaratumab

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN | AUT


No variant requirements are available.